Clinical Trials Browser

Interventional × Advanced Solid Cancers × ADI PEG20 × Clear all

NCT03254732 2022-04-27

Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

Phase 1 Terminated

Advanced Solid Cancers